← Back to all articles
PharmacologyPubMed Verified

Human psychopharmacology of N,N-dimethyltryptamine

Strassman RJ

Behavioural Brain Research (1996)

Randomized Controlled Trial
Abstract

First modern clinical study of IV DMT. Characterized dose-dependent psychoactive, cardiovascular, and neuroendocrine effects in 12 volunteers. Established safety parameters for human DMT research.

Participants12
Citations550
Study TypeRandomized Controlled Trial
DMThuman pharmacologyclinicaldose-response
DOI: 10.1016/0166-4328(96)00081-2View on PubMed

Related Articles

Pharmacology

Pharmacokinetics and pharmacodynamics of an innovative psychedelic N,N-dimethyltryptamine/harmine formulation in healthy participants: a randomized controlled trial

Mueller MJ, Aicher HD et al.

International Journal of Neuropsychopharmacology, 2024
Pharmacology

Dimethyltryptamine and harmine, components of ayahuasca, prevented cocaine-induced apoptosis in SH-SY5Y human neuroblastoma cells

Salles G, de Carvalho Alves I et al.

Archives of Toxicology, 2025
Pharmacology

Development of a physiologically based pharmacokinetic model of N,N-dimethyltryptamine, harmine, and their interactions from ayahuasca in rats and humans

Wittayakarn N, Tan YM et al.

Toxicological Sciences, 2025
Pharmacology

Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelics

Chaves C, Dos Santos RG et al.

Frontiers in Psychiatry, 2024